These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 4393182)

  • 1. Antagonism of D-amphetamine by alpha-methyl-L-tyrosine: behavioral evidence for the participation of catecholamine stores and synthesis in the amphetamine stimulant response.
    Stolk JM; Rech RH
    Neuropharmacology; 1970 May; 9(3):249-63. PubMed ID: 4393182
    [No Abstract]   [Full Text] [Related]  

  • 2. The relationship between amphetamine antagonism and depletion of brain catecholamines by alpha-methyl-p-tyrosine in rats.
    Widerlöv E; Lewander T
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Sep; 304(2):125-34. PubMed ID: 703855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced stimulant effects of d-amphetamine on the spontaneous locomotor activity of rats treated with reserpine.
    Stolk JM; Rech RH
    J Pharmacol Exp Ther; 1967 Oct; 158(1):140-9. PubMed ID: 6054074
    [No Abstract]   [Full Text] [Related]  

  • 4. Evidence for presynaptic dopamine mechanisms underlying amphetamine-conditioned locomotion.
    DiLullo SL; Martin-Iverson MT
    Brain Res; 1992 Apr; 578(1-2):161-7. PubMed ID: 1354997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the effects of d-amphetamine and morphine upon the locomotor activity of mice treated with drugs which alter brain catecholamine content.
    Villarreal JE; Guzman M; Smith CB
    J Pharmacol Exp Ther; 1973 Oct; 187(1):1-7. PubMed ID: 4746328
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of depletion of cerebral monoamines on the concentration of glycogen and on amphetamine-induced glycogenolysis in the brain.
    Hutchins DA; Rogers KJ
    Br J Pharmacol; 1973 May; 48(1):19-29. PubMed ID: 4269287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of reserpine and alpha-methyl-P-tyrosine on norepinephrine and dopamine induced behavioral activity.
    Geyer MA; Segal DS
    Psychopharmacologia; 1973 Mar; 29(2):131-40. PubMed ID: 4709837
    [No Abstract]   [Full Text] [Related]  

  • 8. A comparison of the locomotor stimulant properties of amantadine and l- and d-amphetamine in mice.
    Thornburg JE; Moore KE
    Neuropharmacology; 1972 Sep; 11(5):675-82. PubMed ID: 4151250
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of ECT on dopaminergic and noradrenergic mechanisms. I. Effect on the behavioural changes induced by reserpine, alpha-methyl-p-tyrosine or amphetamine.
    Papeschi R; Randrup A; Lai S
    Psychopharmacologia; 1974 Feb; 35(2):149-58. PubMed ID: 4856059
    [No Abstract]   [Full Text] [Related]  

  • 10. Tolerance to alpha-methyl-p-tyrosine in rats: studies on the antagonism of amphetamine-induced motor activity and excitatory behaviour.
    Widerlöv E; Lewander T
    Psychopharmacology (Berl); 1978 Dec; 60(1):41-5. PubMed ID: 104344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug interactions with brain biogenic amines and the effects of amphetamine isomers on locomotor activity.
    Zabik JE; Levine RM; Maickel RP
    Pharmacol Biochem Behav; 1978 Apr; 8(4):429-35. PubMed ID: 149988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute effects of alpha-methyltyrosine on brain catecholamine levels and on spontaneous and amphetamine-stimulated motor activity in mice.
    Dominic JA; Moore KE
    Arch Int Pharmacodyn Ther; 1969 Mar; 178(1):166-76. PubMed ID: 5353469
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of tyrosine hydroxylase and dopamine-beta-hydroxylase inhibition with the effects of various 6-hydroxydopamine treatments on d-amphetamine induced motor activity.
    Hollister AS; Breese GR; Cooper BR
    Psychopharmacologia; 1974 Mar; 36(1):1-16. PubMed ID: 4151923
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of amantadine and (+)-amphetamine on motility in rats after inhibition of monoamine synthesis and storage.
    Lassen JB
    Psychopharmacologia; 1973 Feb; 29(1):55-64. PubMed ID: 4695207
    [No Abstract]   [Full Text] [Related]  

  • 15. Presynaptic dopaminergic neurotransmission mediates amphetamine-induced unconditioned but not amphetamine-conditioned locomotion and defecation in the rat.
    Di Lullo SL; Martin-Iverson MT
    Brain Res; 1991 Dec; 568(1-2):45-54. PubMed ID: 1726071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of L-DOPA on brain catecholamines and motility in rats.
    Maj J; Grabowska M; Mogilnicka E
    Psychopharmacologia; 1971; 22(2):162-71. PubMed ID: 5124189
    [No Abstract]   [Full Text] [Related]  

  • 17. [Interaction of sydnocarb with preparations influencing the metabolism of catecholamines].
    Al'tshuler RA; Roshchina LF; Mashkovskiĭ MD
    Farmakol Toksikol; 1976; 39(1):9-14. PubMed ID: 943326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depletion of catecholamines in the brain of rats differentially affects stimulation of locomotor activity by caffeine, D-amphetamine, and methylphenidate.
    Finn IB; Iuvone PM; Holtzman SG
    Neuropharmacology; 1990 Jul; 29(7):625-31. PubMed ID: 1974712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of alpha-methyltyrosine on d-amphetamine-induced release of endogenously synthesized and exogenously administered catecholamines from the cat brain in vivo.
    Chiueh CC; Moore KE
    J Pharmacol Exp Ther; 1974 Jul; 190(1):100-8. PubMed ID: 4847307
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of inhibition of catecholamine synthesis on dexamphetamine induced central stimulation.
    Svensson TH
    Eur J Pharmacol; 1970 Oct; 12(2):161-6. PubMed ID: 5472870
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.